EFNA1 and its receptor EPHA2 were upregulated and linked to shorter survival in patients, and activation of the EFNA1/EPHA2 signalling pathway regulated the proliferation and metastasis of oesophageal cancer cells15–17. This evidence concerns the gene EFNA1 and carcinoma of esophagus.